Skip to main content
. 2021 Apr 19;4:71. doi: 10.1038/s41746-021-00427-2

Table 2.

The 5-year AUC for disease-specific survival (DSS) prediction.

Cancer stage Dataset DLS Quantitation of tumor-adipose feature
Stage II Validation set 1 (n = 601 cases) 0.680 [0.631, 0.739] 0.645 [0.598, 0.700]
Validation set 2 (n = 328 cases) 0.663 [0.592, 0.730] 0.634 [0.570, 0.697]
Stage III Validation set 1 (n = 638 cases) 0.655 [0.617, 0.694] 0.629 [0.593, 0.680]
Validation set 2 (n = 410 cases) 0.655 [0.600, 0.707] 0.682 [0.638, 0.743]
Stage II/III Validation set 1 (n = 1239 cases) 0.698 [0.660, 0.729] 0.661 [0.629, 0.694]
Validation set 2 (n = 738 cases) 0.686 [0.638, 0.723] 0.682 [0.641, 0.734]